77 related articles for article (PubMed ID: 6168691)
1. The dual interaction of prostaglandin E2 (PGE2) and interferon (IFN) on NK lytic activation: enhanced capacity of effector-target lytic interactions (recycling) and blockage of pre-NK cell recruitment.
Targan SR
J Immunol; 1981 Oct; 127(4):1424-8. PubMed ID: 6168691
[TBL] [Abstract][Full Text] [Related]
2. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
Flexman JP; Shellam GR
Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
[TBL] [Abstract][Full Text] [Related]
3. The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolytic process: effector activation and NK-cell-target cell conjugate lytic inhibition.
Kendall RA; Targan S
J Immunol; 1980 Dec; 125(6):2770-7. PubMed ID: 7430644
[No Abstract] [Full Text] [Related]
4. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
6. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
Lebow LT; Jewett A; Bonavida B
J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
Linnemeyer PA; Pollack SB
J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
[TBL] [Abstract][Full Text] [Related]
8. Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.
Targan S; Dorey F
J Immunol; 1980 May; 124(5):2157-61. PubMed ID: 6154092
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2.
Leung KH; Koren HS
J Immunol; 1982 Oct; 129(4):1742-7. PubMed ID: 6180022
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents.
Leung KH; Koren HS
J Immunol; 1984 Mar; 132(3):1445-50. PubMed ID: 6319493
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
Muñoz A; Carrasco L; Fresno M
J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
[TBL] [Abstract][Full Text] [Related]
12. Role of interferon in natural kill of HSV-1-infected fibroblasts.
Fitzgerald PA; von Wussow P; Lopez C
J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
[TBL] [Abstract][Full Text] [Related]
13. Modulation of human NK cells by interferon and prostaglandin E2.
Koren HS; Leung KH
Mol Immunol; 1982 Oct; 19(10):1341-6. PubMed ID: 6184617
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergistic effects of interferon on human lymphotoxin activity: a new property of interferon in lymphocyte-mediated target cell killing.
Williams TW
Lymphokine Res; 1984; 3(3):113-8. PubMed ID: 6205226
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
17. Studies of natural killer cells in pregnancy. I. Analysis at the single cell level.
Toder V; Nebel L; Gleicher N
J Clin Lab Immunol; 1984 Jul; 14(3):123-7. PubMed ID: 6207299
[TBL] [Abstract][Full Text] [Related]
18. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
19. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
20. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
Farram E; Targan SR
J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
